Dr. Albert B. Crum
Harvard Medical School
The ProImmune Company, LLC, Founder & CEO
Dr Albert B. Crum, research scientist and renowned physician, has found the way to facilitate intracellular glutathione synthesis in the form on Immune Formulation 200. Utilizing traditional scientific perspectives, Dr. Crum discovered the path that delivers the essential elements required to boost and maintain the natural existing physiology within each and every cell. We can now support natural immune defenses through the granted U.S. Patent RE 39734, underscoring its unique composition, functionality and immune-support potential. The name of Patent RE 39734 is Nutritional or Therapeutic Compounds to Increase Bodily Glutathione Levels.
Implications of Dr. Crum’s invention are most important. This method of glutathione synthesis is reliable, safe, and physiological. Originally, Dr. Crum foresaw the cystine/cysteine interactive reversibility. He did not feel cystine was inert and inactive, notwithstanding it was oxidized. Dr. Crum’s invention foresaw cystine as being the primary systemic carrier of cysteine, hence this coupling’s being the reason why cystine could function as the primary carrier of cysteine. Dr. Crum’s patent is also an economic avenue for replenishment of bodily glutathione.